Mechanism of Inhibition of P-Glycoprotein Mediated Efflux by Vitamin E TPGS:  Influence on ATPase Activity and Membrane Fluidity

Abstract

Efflux pump (e.g., P-gp, MRP1, and BCRP) inhibition has been recognized as a strategy to overcome multi-drug resistance and improve drug bioavailability. Besides small-molecule inhibitors, surfactants such as Tween 80, Cremophor EL, several Pluronics, and Vitamin E TPGS (TPGS 1000) are known to modulate efflux pump activity. Competitive inhibition of substrate binding, alteration of membrane fluidity, and inhibition of efflux pump ATPase have been proposed as possible mechanisms. Focusing on TPGS 1000, the aim of our study was to unravel the inhibitory mechanism by comparing the results of inhibition experiments in a Caco-2 transport assay with data from electron spin resonance (ESR) and from ATPase activity studies. ESR results, on Caco-2 cells using 5-doxyl stearic acid (5-SA) as a spin probe, ruled out cell membrane fluidization as a major contributor; change of membrane fluidity was only observed at surfactant concentrations 100 times higher than those needed to achieve full efflux inhibition. Concurrently, TPGS 1000 inhibited substrate induced ATPase activity without inducing significant ATPase activity on its own. By investigating TPGS analogues that varied by their PEG chain length, and/or possessed a modified hydrophobic core, transport studies revealed that modulation of ATPase activity correlated with inhibitory potential for P-gp mediated efflux. Hence, these results indicate that ATPase inhibition is an essential factor in the inhibitory mechanism of TPGS 1000 on cellular efflux pumps.

Nanoparticules mucopénétrantes : véhicules pour l’administration orale du paclitaxel

“…Dans le même esprit, il nous a semblé que le recours à un système d'administration contenant du poly (éthylène glycol) pouvait être intéressant. Mises à part ses propriétés solubilisantes, cet excipient possède en effet une l'activité inhibitrice de la P-gp et du cytochrome P450 [31,32]. De plus, il est connu que la pégylation des nanoparticules leur confère des propriétés lubrifiantes et muco-adhésives.…”

Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers

“…27 Efflux proteins show a strong efflux effect in low drug concentrations, and become saturated in high drug concentrations. When the Lac-NCTD concentration increased from 100 µg/mL to 400 µg/mL, the ratios of Papp BL-AP to Papp AP-BL decreased from 1.91 to 1.37, respectively.…”

Surfactant-based drug delivery systems for treating drug-resistant lung cancer

“…Then research was preceded by Woodcock et al (1992) which then conclude some other nonionic surfactants, e.g. Tweens, Spans, Cremophors (EL and RH40), Pluronics and vitamin E TPGS having P-gp inhibition Ho et al (2007) action (Collnot et al, 2007). Cremophor EL was used as a component of marketable formulations of paclitaxel (Taxol), however this formulation was found to be toxic.…”